Head-to-head · The Match Score
Ro vs Vaylen
Both scored on the same six-factor Match Score. Ro wins this matchup with a 74 to 63 edge.
Ro
Grade C
Anyone who wants FDA-approved Wegovy or Zepbound and help getting insurance to pay for it.
Visit RoVaylen
Grade C
People comfortable committing to a year who want a needle-free route and a refund if a clinician turns them down.
Visit VaylenFactor by factor
The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.
Price, coverage & formulary
| Detail | Ro | Vaylen |
|---|---|---|
| Semaglutide | $348/mo (starting dose, all-in with the membership, brand-name) | Not disclosed |
| Tirzepatide | $448/mo (starting dose, all-in with the membership, brand-name) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Not listed |
| Oral / sublingual | Yes | Yes |
| Match Score | 74 · C | 63 · C |
Ro edges out Vaylen, 74 to 63 on the default Match Score. Brand-name GLP-1s at manufacturer cash prices — Wegovy pill and pen, Zepbound and the Foundayo pill — plus an insurance concierge, behind a membership billed separately.
Vaylen is still a fair pick if its strengths line up with yours — best for: People comfortable committing to a year who want a needle-free route and a refund if a clinician turns them down.
Worth a look either way: CoreAge Rx, a partner (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.
Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.
More head-to-heads
Or browse alternatives to Ro and all comparisons.
Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.